SCHEMBL4609145

SCHEMBL4609145

COc1c(C=Nc2cccc3nc(C)ccc23)ccc(Cl)c1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
AURKA O14965 1/20 0.34
AURKB Q96GD4 1/20 0.34
HTR1D P28221 2/20 0.34
HTR1B P28222 2/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
TP53 P04637 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
MAPT P10636 2/20 0.32
MAPK1 P28482 2/20 0.32
POLB P06746 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 2/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4609144 1.00 ALDH1A1 (0.37) ALDH1A1AURKAAURKBHTR1DHTR1B
SCHEMBL1726627 0.91 ALDH1A1 (0.37) ALDH1A1AURKAAURKBHTR1DHTR1B
SCHEMBL1726628 0.91 ALDH1A1 (0.37) ALDH1A1AURKAAURKBHTR1DHTR1B
SCHEMBL1727874 0.84 ALDH1A1 (0.38) ALDH1A1AURKAAURKBSMN1; SMN2RXFP1
SCHEMBL1727876 0.84 ALDH1A1 (0.38) ALDH1A1AURKAAURKBSMN1; SMN2RXFP1
SCHEMBL1728141 0.82 NR3C1 (0.42) ALDH1A1AURKAAURKBSMN1; SMN2MAPT
SCHEMBL1728102 0.82 ALDH1A1 (0.37) ALDH1A1AURKAAURKBSMN1; SMN2RXFP1
SCHEMBL1728143 0.82 NR3C1 (0.42) ALDH1A1AURKAAURKBSMN1; SMN2MAPT
SCHEMBL1728103 0.82 ALDH1A1 (0.37) ALDH1A1AURKAAURKBSMN1; SMN2RXFP1
SCHEMBL1728372 0.76 GAA (0.49) ALDH1A1AURKAAURKBSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878717-A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents Bayer Schering Pharma Aktiengesellschaft (DE) 2008-01-16 EP disclosed